SGLT2 Inhibitors: Effect of Dapagliflozin in Patients with Type 2 Diabetes who have inadequate Glycemic Control with Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Authors

Bridget Peterson, Thomas Jefferson University, PGY-3Follow

Document Type

Presentation

Presentation Date

2-5-2015

Abstract

Objectives:

• Review the pathophysiology of DM2 and the pharmacology of oral DM2 agents
• Review the FDA drug approval process
• Critically analyze one of the many recent articles on SGLT2 inhibitors
• Discuss the relevance of this novel class to the care of our patients

Presentation: 28 minutes

Recommended Citation

Peterson, Bridget, "SGLT2 Inhibitors: Effect of Dapagliflozin in Patients with Type 2 Diabetes who have inadequate Glycemic Control with Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial" (2015). Department of Family & Community Medicine Presentations and Grand Rounds. Paper 52.
https://jdc.jefferson.edu/fmlectures/52